Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer

Authors: Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli et al.

Year: 2021

OlaparibSynthetic lethalityBreast cancerHomologous recombinationPoly ADP ribose polymerase